For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue-Product | 0 | - | 0 | 0 |
| Total revenue-Consulting Fees | 0 | - | 0 | 0 |
| Total revenue | 0 | - | 0 | 0 |
| Cost of product sales | 0 | - | 0 | 0 |
| Gross profit (loss) | 0 | - | 0 | 0 |
| Amortization of right of first refusal agreement cost | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 0 | - | - |
| Officers compensation | 30,000 | 30,000 | 30,000 | 30,000 |
| Other operating expenses | 3,376 | 23,806 | 7,412 | 18,251 |
| Total operating expenses | 33,376 | 53,806 | 37,412 | 48,251 |
| Income (loss) from operations | -33,376 | -53,806 | -37,412 | -48,251 |
| Interest expense | 0 | - | - | 885 |
| Note default penalties and interest | - | - | - | 167,417 |
| Gain on conversion of notes payable | - | -376,935* | - | 174,300 |
| Loss on conversion of notes payable | 0 | 20,194* | - | - |
| Interest expense | - | -5,566* | 1,313 | - |
| Total other income (expenses) | 0 | 391,563 | 1,313 | -342,602 |
| Income (gain) before provision for income taxes | -33,376 | 337,757 | -36,099 | -390,853 |
| Provision for income taxes | 0 | - | 0 | 0 |
| Net gain | -33,376 | 337,757 | -36,099 | -390,853 |
| Basic EPS | 0 | 0.409 | -0.04 | 0 |
| Diluted EPS | 0 | 0.409 | -0.04 | 0 |
| Basic Average Shares | 944,935 | 824,984* | 900,256 | 1,286,797,269 |
| Diluted Average Shares | 944,935 | 824,984* | 900,256 | 1,286,797,269 |
Greater Cannabis Company, Inc. (GCAN)
Greater Cannabis Company, Inc. (GCAN)